Pakistan’s Deadly Drug Focus On Six Drug Makers, Three Raided
This article was originally published in PharmAsia News
Executive Summary
Pakistan’s Federal Investigation Agency has turned its focus to six pharmaceutical companies that received contracts to supply allegedly substandard drugs believed to be the cause of death of more than 100 heart patients at a Lahore hospital.